<DOC>
	<DOCNO>NCT00853450</DOCNO>
	<brief_summary>The primary purpose study evaluate effect AZD6482 clopidogrel bleeding time take together low-dose ASA .</brief_summary>
	<brief_title>Bleeding Time Study With AZD6482 , Clopidogrel ASA</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>BMI 19.0 30.0 kg/m2 , inclusive body weight 50.0 100.0 kg , inclusive Provision write informed consent Personal family history bleeding disorder , reasonable suspicion vascular malformation , include aneurysm . Acute illness , surgical procedure trauma 2 week preentry visit first baseline visit clinically significant abnormality clinical chemistry , haematology , urinalysis supine BP pulse Known impair glucose tolerance , know galactose intolerance , total lactase deficiency glucosegalactose malabsorption know suspect Gilbert 's syndrome</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Antiplatelet</keyword>
</DOC>